First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

[Image: see text] STARD3 is a cellular protein that represents an attractive target for cancer therapy, being overexpressed in breast cancer and implied in the development of colorectal, gastric, and prostate cancers. Unfortunately, no STARD3 inhibitor has been identified yet. In this work, an in si...

Full description

Saved in:
Bibliographic Details
Published in:ACS Med Chem Lett
Main Authors: Lapillo, Margherita, Salis, Barbara, Palazzolo, Stefano, Poli, Giulio, Granchi, Carlotta, Minutolo, Filippo, Rotondo, Rossella, Caligiuri, Isabella, Canzonieri, Vincenzo, Tuccinardi, Tiziano, Rizzolio, Flavio
Format: Artigo
Language:Inglês
Published: American Chemical Society 2019
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466518/
https://ncbi.nlm.nih.gov/pubmed/30996782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00509
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items